ammonia n-13
Approved
Aug 23, 2007
Clinical trial activity
9 trials · 13 clinical orgs · 32 marketing orgs
Earliest trial started Feb 1, 2011 (NCT01370265)
Timeline
2000s
- Aug 23, 2007
Feinstein Institute for Medical Research — Earliest FDA Approval
- Aug 23, 2007
Feinstein Institute for Medical Research — NDA Secondary Org
- Aug 23, 2007
Feinstein Institute for Medical Research — NDA Organization
2010s
- Jan 1, 2011
Earliest Phase 1 Sponsor(trial)
- Dec 14, 2012
Houston Cyclotron — Marketing Organization
- Feb 25, 2013
Cardinal Health — Marketing Organization
- Feb 25, 2013
University of Pennsylvania — Marketing Organization
- Jun 27, 2013
University of California, Los Angeles — Marketing Organization
- Dec 9, 2013
Columbia University — Marketing Organization
- Jan 1, 2014
Earliest Phase 2 Sponsor(trial)
- Feb 7, 2014
Washington University in St. Louis — Marketing Organization
- Mar 28, 2014
University of California, San Francisco — Marketing Organization
- Jun 27, 2014
University of Texas at Houston — Marketing Organization
- Aug 19, 2014
Johns Hopkins University — Marketing Organization
- Sep 19, 2014
Shertech Labs Llc — Marketing Organization
- Oct 23, 2014
Zevacor — Marketing Organization
- Oct 23, 2014
Decatur Memorial Hospital — Marketing Organization
- Oct 30, 2014
Harvard University — Marketing Organization
- Nov 20, 2014
Stanford University — Marketing Organization
- Dec 18, 2014
University of Wisconsin — Marketing Organization
- Feb 4, 2015
NCM USA — Marketing Organization
- Apr 22, 2015
Sofie — Marketing Organization
- Apr 23, 2015
Spectron Mrc Llc — Marketing Organization
- Apr 23, 2015
Nukemed — Marketing Organization
- May 1, 2015
Biomedical Research Foundation — Marketing Organization
- Jun 23, 2015
Central Radiopharmaceutical Services Inc. — Marketing Organization
- Aug 14, 2015
Precision Nuclear — Marketing Organization
- Oct 19, 2015
3d Imaging Drug Design & Development — Marketing Organization
- Nov 2, 2015
Siemens — Marketing Organization
- Nov 18, 2015
Midwest Medical Isotopes — Marketing Organization
- Dec 17, 2015
Essential Isotopes, LLC — Marketing Organization
- Feb 3, 2016
Gen Hosp — Marketing Organization
- Dec 21, 2018
Ionetix — Marketing Organization
- Nov 1, 2019
The University of Texas, Dallas — Marketing Organization
2020s
- Jul 9, 2021
Methodist Cancer Center, Houston, Texas — Marketing Organization
- Nov 3, 2022
University of Alabama, Birmingham — Marketing Organization
Indications
Approved for
Mechanism of action
- contrast mediumRadiopaque
contrast medium radiopaque
- UnclearRadiopharmaceutical
Unclear radiopharmaceutical
Approval history
- approvedAug 23, 2007
Chemistry & pharmacology
SMILES
[13NH3]- Mol. weight
- 16.03 g/mol
- Lipinski Ro5
- Pass
- Rule of 3
- Yes
- Chirality
- Achiral Molecule
- Inorganic
- No
- Polymer
- No
- Delivery
- Parenteral
- Availability
- Prescription Only
Oral
No
Parenteral
Yes
Topical
No
Sources
- ChEMBLCHEMBL1201189 ↗
Also known as
- (13n)ammonia
- (13n)ammonia
- 13n-ammonia
- ammonia (13n)
- ammonia (13n)
- ammonia n 13
- ammonia n 13
- ammonia n 13
- ammonia n-13
- ammonia n-13
- ammonia n-13
- ammonia n-13
- ammonia n-13
- n-13 ammonia
- n13 ammonia
- nitrogen-13 ammonia
Clinical trials
| NCT ID | Phase | Start date | Sponsor(s) |
|---|---|---|---|
| NCT05583721 | Phase 2 | Jan 31, 2023 | St. Jude Children's Hospital |
| NCT05625490 | Early Phase 1 (Phase 1) | Nov 11, 2022 | National Heart, Lung, and Blood Institute (NHLBI), National Institutes of Health (NIH), Washington University in St. Louis |
| NCT03549598 | Phase 4 | Jul 20, 2018 | Mayo Clinic |
| NCT03275584 | Phase 4 | Jan 30, 2018 | University of Montreal |
| NCT03236311 | Phase 2 | Oct 12, 2017 | Sanofi |
| NCT02641145 | N/A | Apr 1, 2016 | American Heart Association, Harvard University, National Heart, Lung, and Blood Institute (NHLBI), National Institutes of Health (NIH) |
| NCT02094001 | Phase 2 | May 1, 2014 | Bayer, University of Ottawa |
| NCT01433705 | Phase 1 | Nov 1, 2011 | University of Michigan |
| NCT01370265 | N/A | Feb 1, 2011 | Astellas, Mayo Clinic |
Organizations
Research & Development (13)
| Organization | Org type | Trials | As lead sponsor | Phases | Earliest year |
|---|---|---|---|---|---|
| Mayo Clinic | Academic/Hospital | 2 | 2 | 2 | 2011 |
| National Heart, Lung, and Blood Institute (NHLBI) | Government | 2 | 0 | 2 | 2016 |
| National Institutes of Health (NIH) | Government | 2 | 0 | 2 | 2016 |
| American Heart Association | Academic/Hospital | 1 | 0 | 1 | 2016 |
| Astellas | For profit | 1 | 0 | 1 | 2011 |
| Bayer | For profit | 1 | 0 | 1 | 2014 |
| Harvard University | Academic/Hospital | 1 | 1 | 1 | 2016 |
| Sanofi | For profit | 1 | 1 | 1 | 2017 |
| St. Jude Children's Hospital | Academic/Hospital | 1 | 1 | 1 | 2023 |
| University of Michigan | Academic/Hospital | 1 | 1 | 1 | 2011 |
| University of Montreal | Academic/Hospital | 1 | 1 | 1 | 2018 |
| University of Ottawa | Academic/Hospital | 1 | 1 | 1 | 2014 |
| Washington University in St. Louis | Academic/Hospital | 1 | 1 | 1 | 2022 |
Marketing (36)
| Organization | Org type | Relationship | Date |
|---|---|---|---|
| 3d Imaging Drug Design & Development | For profit | MKTG | Oct 19, 2015 |
| Biomedical Research Foundation | Academic/Hospital | MKTG | May 1, 2015 |
| Cardinal Health | Academic/Hospital | MKTG | Feb 25, 2013 |
| Cardinal Health | Academic/Hospital | SYN | Feb 25, 2013 |
| Central Radiopharmaceutical Services Inc. | For profit | MKTG | Jun 23, 2015 |
| Columbia University | Academic/Hospital | MKTG | Dec 9, 2013 |
| Decatur Memorial Hospital | Academic/Hospital | MKTG | Oct 23, 2014 |
| Essential Isotopes, LLC | For profit | MKTG | Dec 17, 2015 |
| Feinstein Institute for Medical Research | Academic/Hospital | NDA2 | Aug 23, 2007 |
| Feinstein Institute for Medical Research | Academic/Hospital | NDA | Aug 23, 2007 |
| Gen Hosp | Academic/Hospital | MKTG | Feb 3, 2016 |
| Harvard University | Academic/Hospital | MKTG | Oct 30, 2014 |
| Houston Cyclotron | For profit | MKTG | Dec 14, 2012 |
| Ionetix | For profit | MKTG | Dec 21, 2018 |
| Johns Hopkins University | Academic/Hospital | MKTG | Aug 19, 2014 |
| Methodist Cancer Center, Houston, Texas | Academic/Hospital | MKTG | Jul 9, 2021 |
| Midwest Medical Isotopes | For profit | MKTG | Nov 18, 2015 |
| NCM USA | For profit | MKTG | Feb 4, 2015 |
| Nukemed | For profit | MKTG | Apr 23, 2015 |
| Precision Nuclear | For profit | MKTG | Aug 14, 2015 |
| Shertech Labs Llc | For profit | MKTG | Sep 19, 2014 |
| Siemens | For profit | MKTG | Nov 2, 2015 |
| Sofie | For profit | MKTG | Apr 22, 2015 |
| Spectron Mrc Llc | For profit | MKTG | Apr 23, 2015 |
| Stanford University | Academic/Hospital | MKTG | Nov 20, 2014 |
| The University of Texas, Dallas | Academic/Hospital | MKTG | Nov 1, 2019 |
| University of Alabama, Birmingham | Academic/Hospital | MKTG | Nov 3, 2022 |
| University of California, Los Angeles | Academic/Hospital | MKTG | Jun 27, 2013 |
| University of California, San Francisco | Academic/Hospital | MKTG | Mar 28, 2014 |
| University of Pennsylvania | Academic/Hospital | MKTG | Feb 25, 2013 |
| University of Texas at Houston | Academic/Hospital | MKTG | Jun 27, 2014 |
| University of Wisconsin | Academic/Hospital | MKTG | Dec 18, 2014 |
| University of Wisconsin | Academic/Hospital | MKTG | Sep 9, 2020 |
| University of Wisconsin | Academic/Hospital | MKTG | Dec 18, 2014 |
| Washington University in St. Louis | Academic/Hospital | MKTG | Feb 7, 2014 |
| Zevacor | For profit | MKTG | Oct 23, 2014 |